P-Rex1 limits glucose clearance and suppresses hepatocyte glucose uptake and mitochondrial metabolism independently of its Rac-GEF activity
We investigated the roles of Rac guanine-nucleotide exchange factor (Rac-GEF) P-Rex1 in glucose homeostasis using Prex1<sup>-/-</sup> and catalytically inactive Prex1<sup>GD</sup> mice. P-Rex1 maintains fasting blood glucose levels and insulin sensitivity through its Rac-GEF activity but limits glucose clearance independently of its catalytic activity, throughout aging. Prex1<sup>-/-</sup> mice on a high-fat diet are protected from diabetes. The increased glucose clearance in Prex1<sup>-/-</sup> mice may stem in part from constitutively enhanced hepatic glucose uptake. P-Rex1 controls Glut2 surface levels and mitochondrial morphology, membrane potential, and ATP production in hepatocytes, independently of its catalytic activity. The inverse agonist GRA2 showed that P-Rex1 suppresses glucose uptake and mitochondrial ATP production in hepatocytes through the orphan GPCR Gpr21. Cell fractionation showed that P-Rex1 controls Gpr21 trafficking, independently of its catalytic activity. We propose that P-Rex1 limits hepatocyte glucose uptake by retaining Gpr21 at the plasma membrane. These findings delineate new strategies for controlling glucose homeostasis.
Authors
- Heidi C. E. Welch (ORCID: https://orcid.org/0000-0001-7865-7000)
- David C. Hornigold (ORCID: https://orcid.org/0000-0002-3354-2768)
- Kirsty MacLellan‐Gibson (ORCID: https://orcid.org/0000-0002-6734-4452)
- Stephen A. Chetwynd
- Elisa Benetti (ORCID: https://orcid.org/0000-0002-4481-0756)
- Julia Y. Chu
- Polly A. Machin (ORCID: https://orcid.org/0000-0002-8481-8488)
- David A. Baker (ORCID: https://orcid.org/0000-0002-5490-8933)
- Gemma K. Kinsella (ORCID: https://orcid.org/0000-0002-6329-5841)
- Elpida Tsonou (ORCID: https://orcid.org/0000-0002-2363-3391)
- Adam T. McCormack (ORCID: https://orcid.org/0000-0002-7763-3063)
- Anna G Roberts
- John C. Stephens
Institutions
- AstraZeneca (United Kingdom) (GB)
- Babraham Institute (GB)
- National University of Ireland, Maynooth (IE)
- AstraZeneca (South Korea) (KR)
- Technological University Dublin (IE)
- University of Turin (IT)
Publication Details
- Journal
- Cell Reports
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.celrep.2025.116357
- Citations
- 1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.94